TSC1/2 Signaling Complex Is Essential for Peripheral Naïve CD8+ T Cell Survival and Homeostasis in Mice

The PI3K-Akt-mTOR pathway plays crucial roles in regulating both innate and adaptive immunity. However, the role of TSC1, a critical negative regulator of mTOR, in peripheral T cell homeostasis remains elusive. With T cell-specific Tsc1 conditional knockout (Tsc1 KO) mice, we found that peripheral naïve CD8+ T cells but not CD4+ T cells were severely reduced. Tsc1 KO naïve CD8+ T cells showed profound survival defect in an adoptive transfer model and in culture with either stimulation of IL-7 or IL-15, despite comparable CD122 and CD127 expression between control and KO CD8+ T cells. IL-7 stimulated phosphorylation of Akt(S473) was diminished in Tsc1 KO naïve CD8+T cells due to hyperactive mTOR-mediated feedback suppression on PI3K-AKT signaling. Furthermore, impaired Foxo1/Foxo3a phosphorylation and increased pro-apoptotic Bim expression in Tsc1 KO naïve CD8+T cells were observed upon stimulation of IL-7. Collectively, our study suggests that TSC1 plays an essential role in regulating peripheral naïve CD8+ T cell homeostasis, possible via an mTOR-Akt-FoxO-Bim signaling pathway

Temporal Regulation of Rapamycin on Memory CTL Programming by IL-12

Mammalian target of rapamycin (mTOR) is a master regulator of cell growth. Recent reports have defined its important role in memory cytotoxic T lymphocyte (CTL) differentiation in infections and memory programming. We report that rapamycin regulated memory CTL programming by IL-12 to a similar level in a wide range of concentrations, and the enhanced memory CTLs by rapamycin were functional and provided similar protection against Listeria Monocytogenes challenge compared to the control. In addition, rapamycin-experienced CTLs went through substantially enhanced proliferation after transfer into recipients. Furthermore, the regulatory function of rapamycin on CD62L expression in memory CTLs was mainly contributed by the presence of rapamycin in the first 24-hr of stimulation in vitro, whereas the effective window of rapamycin on the size of memory CTLs was determined between 24 to 72 hrs. In conclusion, rapamycin regulates IL-12-driven programming of CTLs to a similar level in a wide range of concentrations, and regulates the phenotype and the size of memory CTLs in different temporal windows

Environmental arginine controls multinuclear giant cell metabolism and formation

Multinucleated giant cells (MGCs) are implicated in many diseases including schistosomiasis, sarcoidosis and arthritis. MGC generation is energy intensive to enforce membrane fusion and cytoplasmic expansion. Using receptor activator of nuclear factor kappa-Beta ligand (RANKL) induced osteoclastogenesis to model MGC formation, here we report RANKL cellular programming requires extracellular arginine. Systemic arginine restriction improves outcome in multiple murine arthritis models and its removal induces preosteoclast metabolic quiescence, associated with impaired tricarboxylic acid (TCA) cycle function and metabolite induction. Effects of arginine deprivation on osteoclastogenesis are independent of mTORC1 activity or global transcriptional and translational inhibition. Arginine scarcity also dampens generation of IL-4 induced MGCs. Strikingly, in extracellular arginine absence, both cell types display flexibility as their formation can be restored with select arginine precursors. These data establish how environmental amino acids control the metabolic fate of polykaryons and suggest metabolic ways to manipulate MGC-associated pathologies and bone remodelling. Multinucleated giant cells (MGCs) are important in the pathogenesis of various diseases. Here, the authors demonstrate that extracellular presence of the amino acid arginine is required for MGC formation and metabolism, suggesting a translational impact for strategies utilizing systemic arginine depletion in MGC-mediated diseases

Responsive Production in Manufacturing: A Modular Architecture

[EN] This paper proposes an architecture aiming at promoting the convergence of the physical and digital worlds, through CPS and IoT technologies, to accommodate more customized and higher quality products following Industry 4.0 concepts. The architecture combines concepts such as cyber-physical systems, decentralization, modularity and scalability aiming at responsive production. Combining these aspects with virtualization, contextualization, modeling and simulation capabilities it will enable self-adaptation, situational awareness and decentralized decision-making to answer dynamic market demands and support the design and reconfiguration of the manufacturing enterprise.The research leading to these results has received funding from the European Union H2020 project C2 NET (FoF-01-2014) nr 636909.Marques, M.; Agostinho, C.; Zacharewicz, G.; Poler, R.; Jardim-Goncalves, R. (2018). Responsive Production in Manufacturing: A Modular Architecture. Studies in Systems, Decision and Control. 140:231-254. https://doi.org/10.1007/978-3-319-78437-3_10S231254140European Commission: For a European Industrial Renaissance, Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions (2014)Hartmann, B., King, W.P., Narayanan, S.: Digital manufacturing: the revolution will be virtualized. McKinsey & Company (2015)European Forum for Manufacture: Driving Innovation and Growth in European Manufacturing (2015)European Factories of the Future Research Association (EFFRA): Factories of the Future: Multi-annual Roadmap for the Contractual PPP under the Horizon 2020 (2013)European Commission: Horizon 2020—Work Programme 2016–2017: 17. Cross-cutting Activities (2016)Schlaepfer, R.C., Koch, M., Merkofer, P.: Industry 4.0 challenges and solutions for the digital transformation and use of exponential technologies. Deloitte AG (2015)7iD: Industry 4.0. https://www.7id.com/technology/industry-4-0/ (2016)European Commission: Horizon 2020—Work Program 2016-2017—Cross-cutting Activities, 25 July 2016EFFRA: Factories of the Future: Multi-annual Roadmap for the Contractual PPP under the Horizon 2020 (2013)FInES Research Roadmap Task Force (2012)Jacinto, J.: Smart manufacturing? Industry 4.0? What’s it all about? Siements Totally Integrated Automation, Automation World & Design World (2014)Monostori, L.: Cyber-physical production systems: roots, expectations and R&D challenges. Procedia CIRP 17, 9–13 (2014)Adolphs, P.: RAMI 4.0—An architectural Model for Industrie 4.0. Platform Industrie 4.0 (2015)Collins, M.: Why America has a shortage of skilled workers. Industry Week (2015)Forbes, J., Naujok, N., Geissbauer, R., Vedso, J., Schrauf, S.: Industry 4.0: building the digital enterprise. PWC (2016)World Economic Forum Industrial Internet Survey (2014)Chen, D., Vernadat, F.B.: Enterprise interoperability: a standardisation view. Enterprise Inter- and Intra-Organizational Integration, Volume 108 of the series IFIP—The International Federation for Information Processing, pp. 273–282 (2003)Yan, L., Li, Z., Yuan, X.: Study on method-of-robust-multidisciplinary-design-collaborative-decision for product design. Inf. Technol. J. 8(4), 441–452 (2009)Ruiz Dominguez, G. A.: Caractérisation de l’activité de conception collaborative à distance: étude des effets de synchronisation cognitive (2005)Jung, J.J.: Reusing ontology mappings for query routing in semantic peer-to-peer environment. Inf. Sci. (2010). https://doi.org/10.1016/j.ins.2010.04.018Ranjan, R., Zhao, L., Wu, X., Liu, A., Quiroz, A., Parashar, M.: Peer-to-Peer Cloud Provisioning: Service Discovery and Load-Balancing. https://doi.org/10.1007/978-1-84996-241-4_12Agostinho, C., Pinto, P., Jardim-goncalves, R.: Dynamic adaptors to support model-driven interoperability and enhance sensing enterprise networks. In: 19th World Congress of the International Federation of Automatic Control (IFAC’14), Cape Town, South Africa (2014)Chen, D., Doumeingts, G., Vernadat, F.: Architectures for enterprise integration and interoperability: past, present and future. Comput. Ind. 59, 647–659 (2008). https://doi.org/10.1016/j.compind.2007.12.016Ducq, Y., Chen, D., Alix, T.: Principles of servitization and definition of an architecture for model driven service system engineering. In: 4th International IFIP Working Conference on Enterprise Interoperability (IWEI 2012), Harbin, China, 2012. https://doi.org/10.1007/978-3-642-33068-17_12Elvesæter, B., Hahn, A., Berre, A., Neple, T.: Towards an interoperability framework for model-driven development of software systems. In: 1st International Conference on Interoperability Enterprise Software and Applications. Springer. http://www.springerlink.com/index/L10NU4306N054T6G.pdf (2005)OMG: MDA Guide Version 1.0.1 (omg/2003-06-01), Object Management Group. http://www.omg.org/cgibin/doc?omg/03-06-01.pdf (2003)Agostinho, C., Ducq, Y., Zacharewicz, G., Sarraipa, J., Lampathaki, F., Poler, R., Jardim-Goncalves, R.: Towards a sustainable interoperability in networked enterprise information systems: trends of knowledge and model-driven technology. Comput. Ind. (2015). https://doi.org/10.1016/j.compind.2015.07.001Santucci, G., Martinez, C., Vlad-câlcic, D.: The sensing enterprise. In: FInES Work. FIA 2012, Aalborg, Denmark. http://www.theinternetofthings.eu/sites/default/files/%5Buser-name%5D/Sensing-enterprise.pdf (2012)Sriram, R.: Smart networked systems and societies: what will the future look like? In: IEEE IT Professional Conference (IT Pro). IEEE Computer Society (2014)Manyika, J., Chui, M., Brown, B., Bughin, J., Dobbs, R., Roxburgh, C., et al.: Big data: the next frontier for innovation, competition, and productivity. http://www.mckinsey.com/insights/business_technology/big_data_the_next_frontier_for_innovation (2011)Zacharewicz, G., Diallo, S., Ducq, Y., Agostinho, C., Jardim-Goncalves, R., Bazoun, H., Wang, Z., Doumeingts, G.: Model-based approaches for interoperability of next generation enterprise information systems: state of the art and future challenges. Inf. Syst. e-Bus. Manag. (2016). https://doi.org/10.1007/s10257-016-0317-8Jardim-Goncalves, R., Agostinho, C., Steiger-Garcao, A.: A reference model for sustainable interoperability in networked enterprises: towards the foundation of EI science base. Int. J. Comput. Integr. Manuf. 25(10) (2012). (Special Issue on Collaborative Manufacturing and Supply Chains). https://doi.org/10.1080/0951192x.2011.653831Schatsky, D., Muraskin, C.: Blockchain is coming to disrupt your industry. Deloitte (2015)Shi, J., Wan, J., Yan, H., Suo, H.: A survey of cyber-physical systems. In: International Conference on Wireless Communications and Signal Processing, pp. 1–6 (2011)Rajkumar, R.: Workshop report on foundations for innovation in cyber-physical systems. NIST. http://www.nist.gov/el/upload/CPS-WorkshopReport-1-30-13-Final.pdf/ (2013)Lee, J., Lapira, E., Yang, S. Kao, H.-A.: Predictive manufacturing system trends of next generation production systems. In: 11th IFAC Workshop on Intelligent Manufacturing Systems, vol. 11, issue 1, pp. 150–156 (2013)IDC: The digital universe of opportunities: rich data and increasing value of the internet of things. EMC Digital Universe. emc.com/collateral/analyst-reports/idc-digital-universe-2014.pdf . (2014)Baheti, R., Gill, H.: Cyber-physical systems. Impact Control Technol. 1–6 (2011)Lee, J., Bagheri, B., Kao, H.-A.: A cyber physical systems architecture for Industry 4.0-based manufacturing system. Manuf. Lett. 2015, 3, 18–23 (2014). https://doi.org/10.1016/j.mfglet.2014.12.001Bagheri, B., Lee, J.: Big future for cyber-physical manufacturing systems. Design World. http://www.designworldonline.com/big-future-for-cyber-physical-manufacturing-systems/ (2015)Lucke, D., Constantinescu, C., Westkämper, E.: Smart factory-a step towards the next generation of manufacturing. Manufacturing Systems and Technologies for the New Frontier, pp. 115–118. Springer, London (2008)Weiser, M.: The Computer for the 21st Century. Scientific American, Special Issue on Communications. Comput. Netw. (1991)Westkämper, E., Jendoubi, L., Eissele, M., Ertl, T.: Smart factory—bridging the gap between digital planning and reality. Manuf. Syst. 35(4), 307–314 (2006)Goryachev, A., Kozhevnikov, S., Kolbova, E., Kuznetsov, O., Simonova, E., Skobelev, P., Tsarev, A., Shepilov, Y.: Smart factory: intelligent system for workshop resource allocation, scheduling, optimization and controlling in real time. Adv. Mater. Res. 630, 508–513 (2012)Agostinho, C., Marques-Lucena, C., Sesana, M., Felic, A., Fischer, K., Rubattino, C., Sarraipa, J.: Osmosis process development for innovative product design and validation. 2015 ASME IMECE, Houston, USA (2015)Ko, J., Lee, B., Lee, K., Hong, S.G., Kim, N., Paek, J.: Sensor virtualization module: virtualizing IoT devices on mobile smartphones for effective sensor data management. Int. J. Distrib. Sens. Netw. (2015). https://doi.org/10.1155/2015/730762Guo, T., Papaioannou, T.G., Aberer, K.: Efficient indexing and query processing of model-view sensor data in the cloud. J. Big Data Res. 1, 52–65 (2014)Kumra, S., Sharma, L., Khanna, Y., Chattri, A.: Analysing an industrial automation pyramid and providing service oriented architecture. Int. J. Eng. Trends Technol. 3(5), 586–594 (2012)Endsley, M.: Design and evaluation for situational awareness enhancement. In: Proceedings of the Human Factors Society 32nd Annual Meeting. HFES, Santa Monica, pp. 97–10 (1988)Stanton, N.A., Chambers, P.R., Piggott, J.: Situational awareness and safety. Saf. Sci. 39(3), 189–204 (2001)Endsley, M.: Toward a theory of situation awareness in dynamic systems. Hum. Factors (The Journal of the Human Factors and Ergonomics Society) 37, 32–64 (1995)Bedny, G., Meister, D.: Theory of activity and situation awareness. Int. J. Cogn. Ergon. 3(1), 63–72 (1999)Smith, K., Hancock, P.A.: Situation awareness is adaptive, externally directed consciousness. Hum. Factors (The Journal of the Human Factors and Ergonomics Society) 37(1), 137–148 (1995)Ranganathan, A., Campbell, R.H.: An infrastructure for context-awareness based on first order logic. Pers. Ubiquit. Comput. 7(6), 353–364 (2003)Ning, K., Scholze, S., Marques, M., Campos, A, Neves-Silva, R. O’Sullivan, D.: A service oriented platform for context aware knowledge enhancing. In: 5th IFAC Conference on Management and Control of Production and Logistics (2010)Marques, M., Sucic, B., Vuk, T.: Context-based decision support for sustainable optimization of energy consumption. KES Trans. Sustain. Des. Manuf. 1(1), 899–910 (2014)Schneeweiss, C.: Distributed decision making in supply chain management. Int. J. Product. Econ. 84, 71–83 (2003)Alemany, M.M.E., Alarcón, F., Lario, F.C., Boj, J.J.: An application to support the temporal and spatial distributed decision-making process in supply chain collaborative planning. Comput. Ind. 62(5), 519–540 (2011). https://doi.org/10.1016/j.compind.2011.02.002Hong, I.H., Ammons, J.C., Realff, M.J.: Centralized versus decentralized decision-making for recycled material flows. Environ. Sci. Technol. 42(4), 1172–1177 (2008)Pibernik, R., Sucky, E.: An approach to inter-domain master planning in supply chains. Int. J. Product. Econ. 108, 200–212 (2007). https://doi.org/10.1016/j.ijpe.2006.12.010Lee, H., Whang, S.: Decentralized multi-echelon supply chains: incentives and information. Manag. Sci. 45(5), 633–640 (1999)Jung, H., Chen, F., Jeong, B.: Decentralized supply chain planning framework for third party logistics partnership. Comput. Ind. Eng. 55(2), 348–364 (2008). https://doi.org/10.1016/j.cie.2007.12.017Wang, K.-J., Chen, M.-J.: Cooperative capacity planning and resource allocation by mutual outsourcing using ant algorithm in a decentralized supply chain. Expert Syst. Appl. 36(2), 2831–2842 (2009)Simon, H.A.: The Science of the Artificial, 1st edn. MIT Press, Cambridge, Mass, (1969). (3rd ed. in 1996, MIT Press)Mesarovic, M.D., Masko, D., Takahara, Y.: Theory of Hierarchical Multilevel Systems. Academic Press, New York and London (1970)Camarinha-Matos, L.M., Afsarmanesh, H.J.: Collaborative networks: a new scientific discipline. J. Intell. Manuf. 16(4), 439–452 (2005)Popplewell, K., Stojanovic, N., Abecker, A., Apostolou, D., Mentzas, G., Harding, J.: Supporting adaptive enterprise collaboration through semantic knowledge services. In: Enterprise Interoperability Iii: New Challenges and Industrial Approaches, pp. 381–393 (2008). http://doi.org/10.1007/978-1-84800-221-0_30Agostinho, C., Ducq, Y., Zacharewicz, G., Sarraipa, J., Lampathaki, F., Jardim-Goncalves, R., Poler, R.: Towards a sustainable interoperability in networked enterprise information systems: trends of knowledge and model-driven technology. Accepted for Publication at Computers in Industry. http://doi.org/10.1016/j.compind.2015.07.001Agostinho, C., Jardim-Gonçalves, R.: Sustaining interoperability of networked liquid-sensing enterprises: a complex systems perspective. Annu. Rev. Control 39, 128–143 (2015). https://doi.org/10.1016/j.arcontrol.2015.03.012Weichhart, G., Molina, A., Chen, D., Whitman, L. E., Vernadat, F.: Challenges and current developments for sensing, smart and sustainable enterprise systems. Computers in Industry (2015). http://doi.org/10.1016/j.compind.2015.07.002Weichhart, G.: Supporting Interoperability for Chaotic and Complex Adaptive Enterprise Systems. On the Move to Meaningful Internet Systems: OTM 2013 Workshops. Confederated International Workshops: OTM Academy, OTM Industry Case Studies Program, ACM, EI2N, ISDE, META4eS, ORM, SeDeS, SINCOM, SMS, and SOMOCO 2013. Proceedings: LNCS 8186, 86–92. (2013). http://doi.org/10.1007/978-3-642-41033-8_14Truex, D.P., Baskerville, R., Klein, H.: Growing systems in emergent organizations. Mag. Commun. ACM CACM Homepage Arch. 42(8), 117–123 (1999)Weiberg, S.: Facilitating collaborative decision-making in six steps. International Association of Facilitators Annual Meeting, pp. 14–15 (1999)Delbecq, A.L., VandeVen, A.H.: A group process model for problem identification and program planning. J. Appl. Behav. Sci. 7, 466–492 (1971). https://doi.org/10.1177/002188637100700404Saaty, T.L.: The Analytic Hierarchy Process. McGraw-Hill, New York, USA (1980

CMV Late Phase-Induced mTOR Activation Is Essential for Efficient Virus Replication in Polarized Human Macrophages : Antiviral Effects of mTOR Inhibitors

Human cytomegalovirus (CMV) remains one of the most important pathogens following solid-organ transplantation. Mounting evidence indicates that mammalian target of rapamycin (mTOR) inhibitors may decrease the incidence of CMV infection in solid- organ recipients. Here we aimed at elucidating the molecular mechanisms of this effect by employing a human CMV (HCMV) infection model in human macrophages, since myeloid cells are the principal in vivo targets of HCMV. We demonstrate a highly di- vergent host cell permissiveness for HCMV with opti- mal infection susceptibility in M2 but not M1 polarized macrophages. Employing an ultrahigh purified HCMV stock we observed rapamycin-independent viral entry and induction of IFN-b transcripts, but no proinflam- matory cytokines or mitogen-activated protein kinases and mTOR activation early after infection. However, in the late infection phase, sustained mTOR activa- tion was observed in HCMV-infected cells and was required for efficient viral protein synthesis including the viral late phase proteins pUL-44 and pp65. Accord- ingly, rapamycin strongly suppressed CMV replication 3 and 5 days postinfection in macrophages. In conclu- sion, these data indicate that mTOR is essential for virus replication during late phases of the viral cycle in myeloid cells and might explain the potent anti-CMV effects of mTOR inhibitors after organ transplantatio

Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy

Adenosine monophosphate-activated protein kinase (AMPK) acts as a major sensor of cellular energy status in cancers and is critically involved in cell sensitivity to anticancer agents. Here, we showed that AMPK was inactivated in lymphoma and related to the upregulation of the mammalian target of rapamycin (mTOR) pathway. AMPK activator metformin potentially inhibited the growth of B- and T-lymphoma cells. Strong antitumor effect was also observed on primary lymphoma cells while sparing normal hematopoiesis ex vivo. Metformin-induced AMPK activation was associated with the inhibition of the mTOR signaling without involving AKT. Moreover, lymphoma cell response to the chemotherapeutic agent doxorubicin and mTOR inhibitor temsirolimus was significantly enhanced when co-treated with metformin. Pharmacologic and molecular knock-down of AMPK attenuated metformin-mediated lymphoma cell growth inhibition and drug sensitization. In vivo, metformin induced AMPK activation, mTOR inhibition and remarkably blocked tumor growth in murine lymphoma xenografts. Of note, metformin was equally effective when given orally. Combined treatment of oral metformin with doxorubicin or temsirolimus triggered lymphoma cell autophagy and functioned more efficiently than either agent alone. Taken together, these data provided first evidence for the growth-inhibitory and drug-sensitizing effect of metformin on lymphoma. Selectively targeting mTOR pathway through AMPK activation may thus represent a promising new strategy to improve treatment of lymphoma patients

Anti-Bacterial Effects of Poly-N-Acetyl-Glucosamine Nanofibers in Cutaneous Wound Healing: Requirement for Akt1

Treatment of cutaneous wounds with poly-N-acetyl-glucosamine nanofibers (sNAG) results in increased kinetics of wound closure in diabetic animal models, which is due in part to increased expression of several cytokines, growth factors, and innate immune activation. Defensins are also important for wound healing and anti-microbial activities. Therefore, we tested whether sNAG nanofibers induce defensin expression resulting in bacterial clearance.The role of sNAG in defensin expression was examined using immunofluoresence microscopy, pharmacological inhibition, and shRNA knockdown in vitro. The ability of sNAG treatment to induce defensin expression and bacterial clearance in WT and AKT1-/- mice was carried out using immunofluoresent microscopy and tissue gram staining. Neutralization, using an antibody directed against β-defensin 3, was utilized to determine if the antimicrobial properties of sNAG are dependent on the induction of defensin expression.sNAG treatment causes increased expression of both α- and β-type defensins in endothelial cells and β-type defensins in keratinocytes. Pharmacological inhibition and shRNA knockdown implicates Akt1 in sNAG-dependent defensin expression in vitro, an activity also shown in an in vivo wound healing model. Importantly, sNAG treatment results in increased kinetics of wound closure in wild type animals. sNAG treatment decreases bacterial infection of cutaneous wounds infected with Staphylococcus aureus in wild type control animals but not in similarly treated Akt1 null animals. Furthermore, sNAG treatment of S. aureus infected wounds show an increased expression of β-defensin 3 which is required for sNAG-dependent bacterial clearance. Our findings suggest that Akt1 is involved in the regulation of defensin expression and the innate immune response important for bacterial clearance. Moreover, these findings support the use of sNAG nanofibers as a novel method for enhancing wound closure while simultaneously decreasing wound infection

Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer

<p>Abstract</p> <p>Background</p> <p>For patients with metastatic renal cell cancer (mRCC) who progressed on vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor therapy, the orally administered mammalian target of rapamycin (mTOR) inhibitor everolimus has been shown to prolong progression free survival. Intriguingly, inhibition of mTOR also promotes expansion of immunosuppressive regulatory T cells (Tregs) that can inhibit anti-tumor immune responses in a clinically relevant way in various tumor types including RCC. This study intends to investigate whether the antitumor efficacy of everolimus can be increased by preventing the detrimental everolimus induced expansion of Tregs using a metronomic schedule of cyclophosphamide.</p> <p>Methods/design</p> <p>This phase I-II trial is a national multi-center study of different doses and schedules of low-dose oral cyclophosphamide in combination with a fixed dose of everolimus in patients with mRCC not amenable to or progressive after a VEGF-receptor tyrosine kinase inhibitor containing treatment regimen. In the phase I part of the study the optimal Treg-depleting dose and schedule of metronomic oral cyclophosphamide when given in combination with everolimus will be determined. In the phase II part of the study we will evaluate whether the percentage of patients progression free at 4 months of everolimus treatment can be increased from 50% to 70% by adding metronomic cyclophosphamide (in the dose and schedule determined in the phase I part). In addition to efficacy, we will perform extensive immune monitoring with a focus on the number, phenotype and function of Tregs, evaluate the safety and feasibility of the combination of everolimus and cyclophosphamide, perform monitoring of selected angiogenesis parameters and analyze everolimus and cyclophosphamide drug levels.</p> <p>Discussion</p> <p>This phase I-II study is designed to determine whether metronomic cyclophosphamide can be used to counter the mTOR inhibitor everolimus induced Treg expansion in patients with metastatic renal cell carcinoma and increase the antitumor efficacy of everolimus.</p> <p>Trial Registration</p> <p>ClinicalTrials.gov Identifier <a href="http://www.clinicaltrials.gov/ct2/show/NCT01462214">NCT01462214</a>, EudraCT number 2010-024515-13, Netherlands Trial Register number <a href="http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=2040">NTR3085</a>.</p